about
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosisThe treatment of multiple sclerosis with inosineAstrocytes: biology and pathologyDiffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disabilityNonconventional MRI and microstructural cerebral changes in multiple sclerosis.Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair.Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating diseaseRole of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cellsA unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis.Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a reviewDeregulated inflammasome signaling in disease.Practical considerations on the use of rituximab in autoimmune neurological disordersMurine whole-organ immune cell populations revealed by multi-epitope-ligand cartography.The Armeo Spring as training tool to improve upper limb functionality in multiple sclerosis: a pilot studyPerfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status.Measuring the effects of aging and sex on regional brain stiffness with MR elastography in healthy older adultsGranzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo.Toll/interleukin-1 receptor domain-containing adapter inducing interferon-β mediates microglial phagocytosis of degenerating axons.Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice.Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesisMyelin repair strategies: a cellular view.An animal model of cortical and callosal pathology in multiple sclerosis.NADPH oxidase in brain injury and neurodegenerative disordersRegulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis.Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.Initial immunopathogenesis of multiple sclerosis: innate immune response.PET imaging in multiple sclerosis.Molecular Mechanisms of the Action of Vitamin A in Th17/Treg Axis in Multiple Sclerosis.Efferent influences on the bioelectrical activity of the retina in primates.Increased axonal expression of nectin-1 in multiple sclerosis plaques.Evaluating upper limb impairments in multiple sclerosis by exposure to different mechanical environments.The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation.Preventing the BDNF and NGF loss involved in the effects of cornel iridoid glycoside on attenuation of experimental autoimmune encephalomyelitis in mice.Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelination.Tackling dipeptidyl peptidase IV in neurological disorders.
P2860
Q21245469-F4B9CAC4-7BC2-4F53-BDB8-5960F3A02731Q24635190-BCFCBEE6-FB16-4AD3-A325-FD6D65FA6B29Q27490746-6FB8BB95-14B0-48D4-8DD9-C80D3E6173A3Q30655532-4EBF9039-FBC9-4870-B5A8-9B09FD089249Q31015218-07D57FD9-81AC-40F1-9CCC-EF1AA6120AC1Q33640136-07330556-95EF-4170-8478-64618A0174FAQ33922879-7F987445-B54B-44B3-B147-9677F762EE8AQ33984937-D2439B70-41B6-4417-B07E-A85539DE2F9BQ34117793-FADDB4BF-0C0B-467D-8D07-EE08E63341FAQ34158137-C07AF7B4-994D-40E0-8FF1-618F0F92FF28Q34212591-9B3FE578-763C-4D8F-88B8-B9C9D83A5196Q34409447-46C02B00-AC1A-424E-A191-70E1C3809606Q34480472-54D265F4-7236-4D3D-889B-5499B4484908Q34567165-736DF8D1-598C-47FB-ACF8-179094227588Q35021647-1FD764B0-0E32-495B-A3BE-62D36ECF60E3Q35286752-51611AF8-6F5E-4BB0-ACD2-391A0485A91EQ36023188-4B7DCD0C-4AEF-4C07-B58E-B40991BD3BE2Q36099505-FBE4E7F0-EDB0-4FFE-975B-EE96B516E838Q36908003-0629C7C3-0D1A-41E2-A35C-4A74B96FEE91Q37130888-B1D80568-AE09-4ADE-9CD5-62289D89A880Q37152685-6F5DA38A-22F8-4081-8B3B-2F41273B797FQ37584143-B735499A-F7D2-4B0D-A4EE-734E277770C2Q37589114-24CB42AF-075F-49B2-8AFB-C21F357E40A7Q37834024-B89D484D-F61E-401F-82C0-562715590B04Q37845414-8B3D52D2-BDA6-4BE0-8C8B-9C550A28FCB2Q38156767-2BE3E6E8-0F22-47B0-BFEC-D3525FD6D9CBQ38210272-8EB4D2FC-90FD-4CBA-A49A-ED5E7CE60B33Q38576288-AAF338D3-DD17-401A-BFB4-AC04D9C39C75Q39061898-B53C4656-333A-4DCE-946F-F926314A010FQ45022862-995BE605-2BB5-4945-802B-4B6B978802F2Q47547204-4D602F29-1DB4-4772-940C-73D5EE229EEAQ48107365-377E5EB8-1DC4-45E9-B5ED-8A8F271A810FQ48642834-D6686619-89F1-4EAD-AD02-F6628A9E93DAQ48844251-6B071478-F58F-45FD-9910-CEABB277C551Q48962920-919B3442-9C26-45F9-9180-0B6E20CADC51Q49940117-C8DBCF43-F33C-4A4D-9DF5-90EF0316AF54
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The Pathology of MS
@ast
The Pathology of MS
@en
The Pathology of MS
@en-gb
The Pathology of MS
@nl
type
label
The Pathology of MS
@ast
The Pathology of MS
@en
The Pathology of MS
@en-gb
The Pathology of MS
@nl
altLabel
The pathology of MS: new insights and potential clinical applications
@en
prefLabel
The Pathology of MS
@ast
The Pathology of MS
@en
The Pathology of MS
@en-gb
The Pathology of MS
@nl
P3181
P1433
P1476
The Pathology of MS
@en
P2093
Claudia F. Lucchinetti
Sean J. Pittock
P3181
P356
10.1097/01.NRL.0000253065.31662.37
P407
P577
2007-03-01T00:00:00Z